• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估基于网络和临床主观认知衰退评估在检测认知障碍方面的准确性:多队列研究。

Evaluating the Accuracy of Web-Based and In-Clinic Subjective Cognitive Decline Assessments in Detecting Cognitive Impairment: Multicohort Study.

作者信息

Kang Jae Myeong, Manjavong Manchumad, Diaz Adam, Ashford Miriam T, Aaronson Anna, Eichenbaum Joseph, Mackin Scott, Tank Rachana, Miller Melanie J, Landavazo Bernard, Cavallone Erika, Truran Diana, Camacho Monica R, Fockler Juliet, Flenniken Derek, Farias Sarah Tomaszewski, Weiner Michael W, Nosheny Rachel

机构信息

VA Advanced Imaging Research Center, San Francisco VA Medical Center, San Francisco, CA, United States.

Department of Psychiatry, Gachon University College of Medicine, Gil Medical Center, Incheon, Republic of Korea.

出版信息

J Med Internet Res. 2025 Aug 11;27:e69689. doi: 10.2196/69689.

DOI:10.2196/69689
PMID:40789142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12338962/
Abstract

BACKGROUND

Scalable tools to efficiently identify individuals likely to have cognitive impairment (CI) are critical in the Alzheimer disease and related dementias field. The Everyday Cognition scale (ECog) and its short form (ECog12) assess subjective cognitive and functional changes and are useful in predicting CI. Recent advances in online technology have enabled the use of web-based cognitive tests and questionnaires to identify CI with greater convenience and scalability. While the effectiveness of the ECog has been demonstrated in clinical settings, its potential to detect CI in remote, unsupervised formats remains underexplored.

OBJECTIVE

This study aimed to compare the ability of the web-based ECog and the in-clinic ECog in distinguishing between individuals with CI and those who are cognitively unimpaired (CU), and to evaluate the effectiveness of the ECog12-the short version of the ECog-compared to the full-length ECog in a web-based setting.

METHODS

Participants were recruited from the Brain Health Registry (BHR; web-based) and Alzheimer's Disease Neuroimaging Initiative (ADNI; in-clinic) settings with available clinical diagnoses. The ability of the self-reported ECog (Self-ECog), study partner-reported ECog (SP-ECog), Self-ECog12, and SP-ECog12 to discriminate individuals with CI from CU was assessed using receiver operating characteristic (ROC) curves. Area under the ROC curves (AUCs) between BHR and ADNI were compared using the DeLong test, as were AUCs between ECog12 and ECog in BHR.

RESULTS

Web-based Self-ECog and SP-ECog scores effectively discriminated CI from CU with AUCs of 0.722 and 0.818, respectively. Similarly, the abbreviated web-based versions, Self-ECog12 and SP-ECog12, also demonstrated discriminative ability (AUC=0.709 and 0.777, respectively). When compared to in-clinic ECog scores, there were no significant differences in the ability to distinguish CI from CU between web-based and in-clinic versions (BHR Self-ECog AUC=0.722 vs ADNI Self-ECog AUC=0.769, DeLong P=.06; BHR SP-ECog AUC=0.818 vs ADNI SP-ECog AUC=0.840, DeLong P=.50). Additionally, the comparison between web-based ECog and ECog12 showed no significant difference in AUCs (BHR Self-ECog AUC=0.722 vs BHR Self-ECog12 AUC=0.709, DeLong P=.18).

CONCLUSIONS

Web-based ECog scores, both the full-length and short-form, were as valid as in-clinic ECog scores for identifying clinically diagnosed CI. In addition, Self-ECog12 was as effective as full-length Self-ECog to identify CI in a web-based setting, offering a cost-effective and accessible screening tool for large-scale studies. These results highlight the value of the web-based ECog as a valid tool for identifying older adults with CI in a remote clinical study, facilitating early detection and referral for comprehensive evaluations for identifying potential candidates for disease-modifying therapy.

摘要

背景

在阿尔茨海默病及相关痴呆症领域,拥有可扩展的工具来有效识别可能患有认知障碍(CI)的个体至关重要。日常认知量表(ECog)及其简版(ECog12)可评估主观认知和功能变化,有助于预测CI。在线技术的最新进展使得基于网络的认知测试和问卷得以应用,从而能更便捷且可扩展地识别CI。虽然ECog在临床环境中的有效性已得到证实,但其在远程、无监督模式下检测CI的潜力仍未得到充分探索。

目的

本研究旨在比较基于网络的ECog与临床使用的ECog在区分CI个体与认知未受损(CU)个体方面的能力,并评估在基于网络的环境中,与完整版ECog相比,ECog简版ECog12的有效性。

方法

从脑健康登记处(BHR;基于网络)和阿尔茨海默病神经影像倡议组织(ADNI;临床环境)招募有可用临床诊断的参与者。使用受试者工作特征(ROC)曲线评估自我报告的ECog(Self-ECog)、研究伙伴报告的ECog(SP-ECog)、Self-ECog12和SP-ECog12区分CI个体与CU个体的能力。使用DeLong检验比较BHR和ADNI之间的ROC曲线下面积(AUC),以及BHR中ECog12和ECog之间的AUC。

结果

基于网络的Self-ECog和SP-ECog分数能有效区分CI与CU,AUC分别为0.722和0.818。同样,基于网络的简版Self-ECog12和SP-ECog12也具有判别能力(AUC分别为0.709和0.777)。与临床ECog分数相比,基于网络的版本和临床版本在区分CI与CU的能力上无显著差异(BHR Self-ECog AUC = 0.722 对 ADNI Self-ECog AUC = 0.769,DeLong P = 0.06;BHR SP-ECog AUC = 0.818 对 ADNI SP-ECog AUC = 0.840,DeLong P = 0.50)。此外,基于网络的ECog与ECog12之间的AUC比较无显著差异(BHR Self-ECog AUC = 0.722 对 BHR Self-ECog12 AUC = 0.709,DeLong P = 0.18)。

结论

基于网络的完整版和简版ECog分数在识别临床诊断的CI方面与临床ECog分数同样有效。此外,Self-ECog12在基于网络的环境中识别CI与完整版Self-ECog同样有效,为大规模研究提供了一种经济高效且可及的筛查工具。这些结果凸显了基于网络的ECog作为在远程临床研究中识别患有CI的老年人的有效工具的价值,有助于早期检测并转诊进行全面评估,以确定疾病修饰治疗的潜在候选者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d769/12338962/eec2aa287c3c/jmir-v27-e69689-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d769/12338962/eec2aa287c3c/jmir-v27-e69689-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d769/12338962/eec2aa287c3c/jmir-v27-e69689-g001.jpg

相似文献

1
Evaluating the Accuracy of Web-Based and In-Clinic Subjective Cognitive Decline Assessments in Detecting Cognitive Impairment: Multicohort Study.评估基于网络和临床主观认知衰退评估在检测认知障碍方面的准确性:多队列研究。
J Med Internet Res. 2025 Aug 11;27:e69689. doi: 10.2196/69689.
2
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
3
Performance of a Short Version of the Everyday Cognition Scale (ECog-12) to Detect Cognitive Impairment.日常认知量表(ECog-12)短版检测认知障碍的性能。
J Prev Alzheimers Dis. 2024;11(6):1741-1750. doi: 10.14283/jpad.2024.109.
4
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
5
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.预测认知衰退:深度学习揭示轻度认知障碍前阶段大脑的细微变化。
J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
8
Subjective cognitive decline predicts longitudinal neuropsychological test performance in an unsupervised online setting in the Brain Health Registry.在大脑健康登记处的无监督在线环境中,主观认知能力下降可预测纵向神经心理学测试表现。
Alzheimers Res Ther. 2025 Jan 7;17(1):10. doi: 10.1186/s13195-024-01641-2.
9
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
10
Self- and Informant-Report Cognitive Decline Discordance and Mild Cognitive Impairment Diagnosis.自我报告与知情者报告的认知衰退不一致性及轻度认知障碍诊断
JAMA Netw Open. 2025 Apr 1;8(4):e255810. doi: 10.1001/jamanetworkopen.2025.5810.

本文引用的文献

1
Subjective cognitive decline predicts longitudinal neuropsychological test performance in an unsupervised online setting in the Brain Health Registry.在大脑健康登记处的无监督在线环境中,主观认知能力下降可预测纵向神经心理学测试表现。
Alzheimers Res Ther. 2025 Jan 7;17(1):10. doi: 10.1186/s13195-024-01641-2.
2
Performance of a Short Version of the Everyday Cognition Scale (ECog-12) to Detect Cognitive Impairment.日常认知量表(ECog-12)短版检测认知障碍的性能。
J Prev Alzheimers Dis. 2024;11(6):1741-1750. doi: 10.14283/jpad.2024.109.
3
[Not Available].
[无可用内容]
Alzheimers Dement (N Y). 2024 Apr 24;10(2):e12465. doi: 10.1002/trc2.12465. eCollection 2024 Apr-Jun.
4
Unsupervised Online Paired Associates Learning Task from the Cambridge Neuropsychological Test Automated Battery (CANTAB®) in the Brain Health Registry.大脑健康登记处中来自剑桥神经心理测试自动成套系统(CANTAB®)的无监督在线配对联想学习任务。
J Prev Alzheimers Dis. 2024;11(2):514-524. doi: 10.14283/jpad.2023.117.
5
Evaluation of the Electronic Clinical Dementia Rating for Dementia Screening.电子临床痴呆评定量表用于痴呆筛查的评估。
JAMA Netw Open. 2023 Sep 5;6(9):e2333786. doi: 10.1001/jamanetworkopen.2023.33786.
6
Research on digital tool in cognitive assessment: a bibliometric analysis.认知评估中数字工具的研究:一项文献计量分析。
Front Psychiatry. 2023 Aug 23;14:1227261. doi: 10.3389/fpsyt.2023.1227261. eCollection 2023.
7
Brain health registry updates: An online longitudinal neuroscience platform.脑健康登记更新:一个在线纵向神经科学平台。
Alzheimers Dement. 2023 Nov;19(11):4935-4951. doi: 10.1002/alz.13077. Epub 2023 Apr 18.
8
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4.增加 AD 研究中的参与者多样性:在阿尔茨海默病神经影像学倡议 4 中进行数字筛查、血液检测和社区参与方法的计划。
Alzheimers Dement. 2023 Jan;19(1):307-317. doi: 10.1002/alz.12797. Epub 2022 Oct 9.
9
Development and implementation of an electronic Clinical Dementia Rating and Financial Capacity Instrument-Short Form.电子临床痴呆评定和财务能力工具简表的开发与实施
Alzheimers Dement (Amst). 2022 Jul 24;14(1):e12331. doi: 10.1002/dad2.12331. eCollection 2022.
10
Validity of Online Versus In-Clinic Self-Reported Everyday Cognition Scale.在线与门诊自我报告日常认知量表的有效性。
J Prev Alzheimers Dis. 2022;9(2):269-276. doi: 10.14283/jpad.2022.20.